Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$4.3 million.

  • Rockwell Medical's Cash from Investing Activities rose 29.50% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.7 million, marking a year-over-year decrease of 87.85%. This contributed to the annual value of -$4.9 million for FY2024, which is 59.80% down from last year.
  • As of Q3 2025, Rockwell Medical's Cash from Investing Activities stood at -$4.3 million, which was down 4,083.50% from -$103,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Cash from Investing Activities ranged from a high of $9.1 million in Q1 2022 and a low of -$14.7 million during Q3 2022.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$103,000 (2025), whereas its average is -$1.1 million.
  • As far as peak fluctuations go, Rockwell Medical's Cash from Investing Activities slumped by 977.42% in 2022, and later spiked by 2,782.81% in 2024.
  • Over the past 5 years, Rockwell Medical's Cash from Investing Activities (Quarterly) stood at $540,000 in 2021, then soared by 495.93% to $3.2 million in 2022, then slumped by 37.60% to $2.0 million in 2023, then crashed by 116.53% to -$332,000 in 2024, then climbed by 29.50% to -$4.3 million in 2025.
  • Its Cash from Investing Activities was -$4.3 million in Q3 2025, compared to -$103,000 in Q2 2025 and -$1,000 in Q1 2025.